Isomorphic Labs announces strategic collaborations with Eli Lilly and Company and Novartis.
Isomorphic Labs announces strategic collaborations with two of the world’s leading pharmaceutical companies, Eli Lilly and Company and Novartis. Both collaborations are multi-target, focused on small molecules, and include a combination of upfront and milestone payments. These partnerships have the…